Top

Published in:

Open Access 01-12-2008 | Research article

Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON^®TB Gold with tuberculin skin test

Authors: Brita Askeland Winje, Fredrik Oftung, Gro Ellen Korsvold, Turid Mannsåker, Anette Skistad Jeppesen, Ingunn Harstad, Berit Tafjord Heier, Einar Heldal

Published in: BMC Infectious Diseases | Issue 1/2008

Abstract

Background

QuantiFERON^®TB Gold (QFT) is a promising blood test for tuberculosis infection but with few data so far from immigrant screening. The aim of this study was to compare results of QFT and tuberculin skin test (TST) among newly arrived asylum seekers in Norway and to assess the role of QFT in routine diagnostic screening for latent tuberculosis infection.

Methods

The 1000 asylum seekers (age ≥ 18 years) enrolled in the study were voluntarily recruited from 2813 consecutive asylum seekers arriving at the national reception centre from September 2005 to June 2006. Participation included a QFT test and a questionnaire in addition to the mandatory TST and chest X-ray.

Results

Among 912 asylum seekers with valid test results, 29% (264) had a positive QFT test whereas 50% (460) tested positive with TST (indurations ≥ 6 mm), indicating a high proportion of latent infection within this group. Among the TST positive participants 50% were QFT negative, whereas 7% of the TST negative participants were QFT positive. There was a significant association between increase in size of TST result and the likelihood of being QFT positive. Agreement between the tests was 71–79% depending on the chosen TST cut-off and it was higher for non-vaccinated individuals.

Conclusion

By using QFT in routine screening, further follow-up could be avoided in 43% of the asylum seekers who would have been referred if based only on a positive TST (≥ 6 mm). The proportion of individuals referred will be the same whether QFT replaces TST or is used as a supplement to confirm a positive TST, but the number tested will vary greatly. All three screening approaches would identify the same proportion (88–89%) of asylum seekers with a positive QFT and/or a TST ≥ 15 mm, but different groups will be missed.

Available only for authorised users

Winje BA, Mannsåker T, Heldal E, Dahle UR: Tuberkulose i Norge 2006 (Norwegian only). MSIS-rapport. 2007, 35: [http://www.fhi.no/dav/95768e290c.pdf]

Dahle UR, Sandven P, Heldal E, Caugant DA: Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2003, 41: 2968-2973. 10.1128/JCM.41.7.2968-2973.2003.CrossRefPubMedPubMedCentral

Dahle UR, Eldholm V, Winje BA, Mannsaker T, Heldal E: Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med. 2007, 176: 930-935. 10.1164/rccm.200702-187OC.CrossRefPubMed

Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999, 282: 677-686. 10.1001/jama.282.7.677.CrossRefPubMed

Folkehelseinstituttet: Forebygging og kontroll av tuberkulose: en veileder (Guidelines for prevention and control of tuberculosis). 2002, Oslo, Folkehelseinstituttet, 122-7

Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet. 2000, 356: 1099-1104. 10.1016/S0140-6736(00)02742-2.CrossRefPubMed

Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016/S1473-3099(04)01206-X.CrossRefPubMed

Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW: Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007, 175: 618-627. 10.1164/rccm.200608-1099OC.CrossRefPubMed

Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003, 361: 1168-1173. 10.1016/S0140-6736(03)12950-9.CrossRefPubMed

10.

Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005, 293: 2756-2761. 10.1001/jama.293.22.2756.CrossRefPubMed

11.

Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, Reece WH, Latif M, Pasvol G, Hill AV: Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001, 357: 2017-2021. 10.1016/S0140-6736(00)05115-1.CrossRefPubMed

12.

Richeldi L, Ewer K, Losi M, Bergamini BM, Roversi P, Deeks J, Fabbri LM, Lalvani A: T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med. 2004, 170: 288-295. 10.1164/rccm.200403-307OC.CrossRefPubMed

13.

Carvalho AC, Pezzoli MC, El Hamad I, Arce P, Bigoni S, Scarcella C, Indelicato AM, Scolari C, Carosi G, Matteelli A: QuantiFERON((R))-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect. 2007, 55: 164-168. 10.1016/j.jinf.2007.02.004.CrossRefPubMed

14.

Health RM: Regulations. Regulations on the Control of Tuberculosis. Issued by the Royal Ministry of Health on 21st June 2002. 2002, Royal Ministry of Health, I-1095E

15.

Altman DG: Statistics with confidence. Confidence intervals and statistical guidelines. Edited by: Altman DG, D M, N BT and J GM. 2000, BMJ Books, 240-2nd

16.

Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, Ewer K, Hill AV, Mehta A, Rodrigues C: Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis. 2001, 183: 469-477. 10.1086/318081.CrossRefPubMed

17.

Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, Little F, Hanekom WA, Geiter L, Hussey GD: Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis. 2006, 10: 310-316.PubMed

18.

Pai M, Kalantri S, Dheda K: New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006, 6: 413-422. 10.1586/14737159.6.3.413.CrossRefPubMed

19.

Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, Ewer K, Barnes PF: Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med. 2005, 172: 1161-1168. 10.1164/rccm.200505-748OC.CrossRefPubMedPubMedCentral

20.

Comstock GW, Livesay VT, Woolpert SF: The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974, 99: 131-138.PubMed

21.

Bahrmand AR, Madani H, Samar G, Khalilzadeh L, Bakayev VV, Yaghli M, Babaei MH: Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients. Scand J Infect Dis. 1996, 28: 275-278. 10.3109/00365549609027172.CrossRefPubMed

22.

von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, Weber DJ, Tosteson AN: Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis. 2001, 5: 1122-1128.PubMed

23.

Berkel GM, Cobelens FG, de Vries G, Draayer-Jansen IW, Borgdorff MW: Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis. 2005, 9: 310-316.PubMed

24.

Nguyen M, Perry S, Parsonnet J: QuantiFERON-TB predicts tuberculin skin test boosting in U.S. foreign-born. Int J Tuberc Lung Dis. 2005, 9: 985-991.PubMed

25.

Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM: Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific IFN-{gamma} assay. Eur Respir J. 2007, 29: 1212-1216. 10.1183/09031936.00117506.CrossRefPubMed

26.

Drobniewski F, Cobelens F, J-P Z: Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006. Eurosurveillance weekly 2007, 12: [http://www.eurosurveillance.org/ew/2007/070726.asp#2 ].

27.

Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM: A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002, 57: 804-809. 10.1136/thorax.57.9.804.CrossRefPubMedPubMedCentral

28.

Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A: Predictive Value of a Whole-blood IFN-{gamma} Assay for the Development of Active TB Disease. Am J Respir Crit Care Med. 2008

29.

Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT: Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol. 2007, 14: 880-885. 10.1128/CVI.00132-07.CrossRefPubMedPubMedCentral

30.

Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Otu JK, Corrah T, Adegbola RA, McAdam KP: Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004, 38: 966-973. 10.1086/382362.CrossRefPubMed

31.

Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM: Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005, 293: 2746-2755. 10.1001/jama.293.22.2746.CrossRefPubMed

32.

Lalvani A, Richeldi L, Kunst H: Interferon gamma assays for tuberculosis. Lancet Infect Dis. 2005, 5: 322-324. 10.1016/S1473-3099(05)70118-3.CrossRefPubMed

33.

Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A: Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005, 54: 49-55.PubMed

34.

Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA: Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis. 2007, 45: 837-845. 10.1086/521107.CrossRefPubMed

35.

Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170: 59-64. 10.1164/rccm.200402-179OC.CrossRefPubMed

36.

Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A: Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS. 2002, 16: 2285-2293. 10.1097/00002030-200211220-00008.CrossRefPubMed

37.

Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P: Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res. 2006, 7: 56-10.1186/1465-9921-7-56.CrossRefPubMedPubMedCentral

38.

Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H: Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis. 2007, 11: 1190-1195.PubMed

39.

Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M: Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J. 2007, 30: 945-950. 10.1183/09031936.00040007.CrossRefPubMed

40.

Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV: Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007, 175: 737-742. 10.1164/rccm.200608-1088OC.CrossRefPubMedPubMedCentral

41.

Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004, 170: 65-69. 10.1164/rccm.200402-232OC.CrossRefPubMed

42.

Codecasa L, Mantegani P, Galli L, Lazzarin A, Scarpellini P, Fortis C: An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. J Clin Microbiol. 2006, 44: 1944-1950. 10.1128/JCM.02265-05.CrossRefPubMedPubMedCentral

43.

Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T: Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res. 2006, 7: 77-10.1186/1465-9921-7-77.CrossRefPubMedPubMedCentral

44.

Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P: Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis. 2005, 9: 1242-1247.PubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/8/65/prepub

Title: Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON®TB Gold with tuberculin skin test
Authors: Brita Askeland Winje
Fredrik Oftung
Gro Ellen Korsvold
Turid Mannsåker
Anette Skistad Jeppesen
Ingunn Harstad
Berit Tafjord Heier
Einar Heldal
Publication date: 01-12-2008
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2008
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/1471-2334-8-65

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON^®TB Gold with tuberculin skin test

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2008

Potential impact of infant feeding recommendations on mortality and HIV-infection in children born to HIV-infected mothers in Africa: a simulation

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico

Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa

The United States and Canada as a coupled epidemiological system: An example from hepatitis A

Take the sex out of STI screening! Views of young women on implementing chlamydia screening in General Practice

HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page